关注
Jason M White
Jason M White
在 unisa.edu.au 的电子邮件经过验证
标题
引用次数
引用次数
年份
Mechanisms of fatal opioid overdose
JM White, RJ Irvine
Addiction 94 (7), 961-972, 1999
8011999
Alpha2adrenergic agonists for the management of opioid withdrawal
L Gowing, M Farrell, R Ali, JM White
Cochrane Database of Systematic Reviews, 2016
5052016
The nature, time course and severity of methamphetamine withdrawal
C McGregor, M Srisurapanont, J Jittiwutikarn, S Laobhripatr, T Wongtan, ...
Addiction 100 (9), 1320-1329, 2005
4592005
Buprenorphine for the management of opioid withdrawal
L Gowing, R Ali, JM White
Cochrane Database of Systematic Reviews, 2009
4372009
The prevalence of alcohol, cannabinoids, benzodiazepines and stimulants amongst injured drivers and their role in driver culpability: part ii: the relationship between drug …
MC Longo, CE Hunter, RJ Lokan, JM White, MA White
Accident Analysis & Prevention 32 (5), 623-632, 2000
4152000
Buprenorphine versus methadone maintenance therapy: a randomized doubleblind trial with 405 opioiddependent patients
RP Mattick, R Ali, JM White, S O'Brien, S Wolk, C Danz
Addiction 98 (4), 441-452, 2003
3702003
Hyperalgesic responses in methadone maintenance patients
M Doverty, JM White, AA Somogyi, F Bochner, R Ali, W Ling
Pain 90 (1-2), 91-96, 2001
3642001
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group
Lancet (London, England) 397 (10274), 605, 2021
3212021
Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial
M Dennis, G Mead, J Forbes, C Graham, M Hackett, GJ Hankey, A House, ...
The Lancet 393 (10168), 265-274, 2019
2832019
New psychoactive substances: challenges for drug surveillance, control, and public health responses
A Peacock, R Bruno, N Gisev, L Degenhardt, W Hall, R Sedefov, J White, ...
The Lancet 394 (10209), 1668-1684, 2019
2702019
Exposure to opioid maintenance treatment reduces longterm mortality
A Gibson, L Degenhardt, RP Mattick, R Ali, J White, S O'Brien
Addiction 103 (3), 462-468, 2008
2572008
Buprenorphine for managing opioid withdrawal
L Gowing, R Ali, JM White, D Mbewe
Cochrane Database of Systematic Reviews, 2017
219*2017
Hyperalgesia in opioid-managed chronic pain and opioid-dependent patients
JL Hay, JM White, F Bochner, AA Somogyi, TJ Semple, B Rounsefell
The Journal of Pain 10 (3), 316-322, 2009
2172009
Opioid antagonists with minimal sedation for opioid withdrawal
L Gowing, R Ali, JM White
Cochrane Database of Systematic Reviews, 2017
2112017
Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine
M Doverty, AA Somogyi, JM White, F Bochner, CH Beare, A Menelaou, ...
Pain 93 (2), 155-163, 2001
2082001
Psychosocial treatment for methamphetamine use disorders: A preliminary randomized controlled trial of cognitive behavior therapy and acceptance and commitment therapy
MF Smout, M Longo, S Harrison, R Minniti, W Wickes, JM White
Substance abuse 31 (2), 98-107, 2010
2052010
Health status at entry to methadone maintenance treatment using the SF36 health survey questionnaire
CF Ryan, JM White
Addiction 91 (1), 39-45, 1996
1931996
Population drug use in Australia: a wastewater analysis
RJ Irvine, C Kostakis, PD Felgate, EJ Jaehne, C Chen, JM White
Forensic science international 210 (1-3), 69-73, 2011
1912011
Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial
RAS Salman, MS Dennis, PAG Sandercock, CLM Sudlow, JM Wardlaw, ...
The Lancet 393 (10191), 2613-2623, 2019
1862019
Strength at the extracellular matrix–muscle interface
MD Grounds, L Sorokin, J White
Scandinavian journal of medicine & science in sports 15 (6), 381-391, 2005
1862005
系统目前无法执行此操作,请稍后再试。
文章 1–20